Published in Cancer Cell on December 13, 2016
m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell (2017) 1.41
Genetic alterations of m(6)A regulators predict poorer survival in acute myeloid leukemia. J Hematol Oncol (2017) 1.39
m(6)A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells. Cell Rep (2017) 0.75
RNA editing-dependent epitranscriptome diversity in cancer stem cells. Nat Rev Cancer (2017) 0.75
Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer. Cancers (Basel) (2017) 0.75
Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res (2017) 0.75
The N(6)-Methyladenosine RNA modification in pluripotency and reprogramming. Curr Opin Genet Dev (2017) 0.75
Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N(6)-Adenosine Methylation to Promote Lytic Replication. J Virol (2017) 0.75
N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet (2007) 14.99
Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet (2007) 13.62
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature (2012) 7.00
Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell (2012) 6.99
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood (1988) 6.09
N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol (2011) 5.96
hDOT1L links histone methylation to leukemogenesis. Cell (2005) 5.83
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med (2013) 5.72
Inactivation of the Fto gene protects from obesity. Nature (2009) 5.61
Acute promyelocytic leukemia: from highly fatal to highly curable. Blood (2008) 5.35
N6-methyladenosine-dependent regulation of messenger RNA stability. Nature (2013) 4.70
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell (2011) 4.56
Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet (2010) 4.37
N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol (2014) 4.19
ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell (2012) 4.18
Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A (1974) 3.94
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol Cell Biol (2004) 3.62
A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol (2013) 3.16
Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA (1997) 2.89
Acute Myeloid Leukemia. N Engl J Med (2015) 2.85
Gene expression regulation mediated through reversible m⁶A RNA methylation. Nat Rev Genet (2014) 2.60
Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science (2015) 2.56
Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res (2014) 2.36
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A (2009) 2.34
The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol (2014) 2.19
Leukaemogenesis: more than mutant genes. Nat Rev Cancer (2010) 2.16
N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell (2015) 2.15
Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet (2009) 2.09
N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature (2015) 2.09
Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites. Cell Rep (2014) 2.04
Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood (1999) 2.02
Reversible RNA adenosine methylation in biological regulation. Trends Genet (2012) 1.93
Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc (2013) 1.91
Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature (2015) 1.90
FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res (2014) 1.80
5' UTR m(6)A Promotes Cap-Independent Translation. Cell (2015) 1.75
The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS One (2010) 1.67
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. Cancer Cell (2012) 1.61
N6-methyladenosine marks primary microRNAs for processing. Nature (2015) 1.58
The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci (2013) 1.57
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun (2012) 1.49
The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur J Hum Genet (2010) 1.45
N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics (2012) 1.41
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. Haematologica (2008) 1.40
The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer Cell (2013) 1.38
Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics. Curr Opin Hematol (2005) 1.36
RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev (2015) 1.29
Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells. Blood (2015) 1.26
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells. Blood (2015) 1.26
m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. Cell Stem Cell (2015) 1.25
TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A (2013) 1.19
Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia. J Exp Med (2013) 1.15
AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. Blood (2013) 1.10
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci U S A (2016) 1.08
Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways. Blood (2004) 1.05
Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood (2012) 1.04
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J Biol Chem (2001) 1.03
ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood (2011) 0.99
ATRA-regulated Asb-2 gene induced in differentiation of HL-60 leukemia cells. FEBS Lett (2001) 0.97
Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3. Br J Haematol (2001) 0.96
Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer (2008) 0.96
Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls. Tumour Biol (2012) 0.95
Exome-based analysis for RNA epigenome sequencing data. Bioinformatics (2013) 0.94
miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat Commun (2016) 0.92
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid. Leuk Lymphoma (2004) 0.88
Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region. Blood Cancer J (2014) 0.87
Lineage restriction of the RARalpha gene expression in myeloid differentiation. Blood (2001) 0.86
FTO: linking m6A demethylation to adipogenesis. Cell Res (2014) 0.83
Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway. Hum Mol Genet (2014) 0.82
NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells. PLoS One (2014) 0.78
Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia. Cancer Lett (2016) 0.76